ZYDG2, a Potent, Selective, and Safe GPR40 Agonist for Treatment of Type 2 Diabetes von JAIN, MUKUL R., GIRI, SURESH R., TRIVEDI, CHITRANG J., BHOI, BIBHUTI B., RATH, AKSHYAYA CHANDAN, RATHOD, ROHAN MANUBHAI, SUNDAR, RAJESH, BANDYOPADHYAY, DEBDUTTA, RAMDHAVE, RASHMI, PATEL, GAUTAM D., SRIVASTAVA, BRIJESH KUMAR, DESAI, RANJIT C.

Volltext